IVD devices enable earlier breast cancer diagnoses than mammograms, and detect genetic abnormalities that can contribute to ...
4d
Tempus Receives U.S. FDA 510(k) Clearance for Tempus xR IVD, its RNA NGS In Vitro Diagnostic Device
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...
Zacks.com on MSN
Tempus AI Enhances Cancer Research Tools With FDA-Cleared xR IVD
RNA sequencing provides a comprehensive view of biological information, offering deeper insights into disease mechanisms, ...
Tempus AI shares are trading higher Monday morning. The company announced it has received U.S. Food and Drug Administration ...
Representing significant positions in more than one of Ark Invest's exchange-traded funds (ETFs), Tempus AI is ending the ...
CDSCO simplifies online provision for import of medical devices & IVD already approved by CLA: Gireesh Babu, New Delhi ...
Now, a separate provision for 'Subsequent Importer' has been made functional w.e.f. 11.09.2025 in the CDSCO online portal ...
Quality Control Market Size is projected to grow at a CAGR of 6.66% from 2024 to 2031, according to a new report published by Verified Market Research®. The report reveals that the market was valued ...
Ark Invest decided to sell shares of Tempus AI (TEM), despite positive news of FDA clearance for its diagnostic device. They ...
Investing.com -- Tempus AI, Inc. (NASDAQ:TEM) stock rose 5% on Monday after the company announced it received 510 (k) clearance from the U.S. Food and Drug Administration for its RNA-based Tempus xR ...
The U.S. FDA issued a pair of final guidances this week, including one that outlines the criteria for authorizing emergency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback